This page shows the publications co-authored by Mark Siedner and Rajesh Gandhi.
Proposing Minimum Requirements for Announcing Clinical Trial Results During the COVID-19 Pandemic. Clin Infect Dis. 2021 04 08; 72(7):1265-1267.
False-positive HIV testing in patients receiving lentivirus-based chimeric antigen receptor T-cell therapy: A case report, review of the literature and proposed recommendations. J Infect Dis. 2021 Dec 20.
Who's slipping through the cracks? A comprehensive individual, clinical and health system characterization of people with virological failure on first-line HIV treatment in Uganda and South Africa. HIV Med. 2022 May; 23(5):474-484.
Resistance Testing for Management of HIV Virologic Failure in Sub-Saharan Africa : An Unblinded Randomized Controlled Trial. Ann Intern Med. 2021 12; 174(12):1683-1692.
Desperate Times Call for Temperate Measures: Practicing Infectious Diseases During a Novel Pandemic. J Infect Dis. 2020 09 01; 222(7):1084-1085.
The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimates. HIV Clin Trials. 2017 07; 18(4):149-155.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.